Sanofi-Aventis Deutschland GmbH

Sanofi-Aventis Deutschland GmbH is the German subsidiary of the global pharmaceutical company Sanofi. Headquartered at Industriepark Höchst in Frankfurt am Main, it stands as the largest integrated site for research, development, and production within the Sanofi Group. As of 2023, the company employed approximately 6,600 of its 8,000 German staff at this location. Notably, the Frankfurt-Höchst site is responsible for producing Insulin glargin (Lantus), which ranked among the top five global pharmaceutical products by revenue in 2014. Wikipedia

Patent Strategy

Sanofi-Aventis Deutschland GmbH employs a robust patent strategy to safeguard its pharmaceutical innovations, particularly in drug delivery systems. The company's approach encompasses the development of advanced medical devices and the defense of its intellectual property rights through litigation and strategic licensing.